Therapeutic Use (Phase IV)

1,197 trials 558 recruiting

Filter these 1,197 trials by condition, country, sponsor and more.

Open in Search →

VALSARTAN TREATMENT COMPARED IN RENAL TRANSPLANT RECIPIENTS WITH SIGNS OF POST TRANSPLANT GLOMERULOPATHY Ended

2024-518723-30-01 Renal transplant patients 2024-10-16
Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point… Ended

2024-511530-12-01 Rheumatoid arthritis according to 2010 criteria 2024-10-01
Combination therapy of 5-Fluorouracil and Calcipotriol versus 5-Fluorouracil in the treatment of Actinic Keratosis: a multicentre randomized… Ended

2024-511409-42-00 Actinic Keratosis 2024-09-02
Rivaroxaban Monotherapy and CYP2C19 Genotype Testing in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention Ended

2023-508904-39-00 Coronary artery disease 2024-08-22
A study to investigate long-term follow-up in subjects who received BMN 270 in a prior BioMarin Clinical Trial with hemophilia A Ended

2023-507749-27-00 Hemophilia A 2024-08-16
MAD Ended

2024-516379-34-00 Myopia 2024-08-02
A Study on Diclofenac vs. Placebo for Knee Osteoarthritis Ended

2024-510757-95-01 Knee osteoarthritis 2024-08-01
Personalized extended interval dosing of natalizumab in relapsing remitting multiple sclerosis (NEXT-MS) Ended

2024-513105-31-00 Multiple Sclerosis 2024-07-30
DUTCH-WAIST Ended

2022-501392-81-00 Obesity 2024-07-25
A study concerning the influence of tubal flushing with oil on pregnancy and live birth in women with fertility problems Ended

2023-508896-35-00 Infertile women with at least one patent tube at Hyster 2024-07-12
Vaccination to prevent Mpox Infection (MPOX-VAX Study) Ended

2023-507881-19-00 Mpox infection 2024-06-29
Study of Empagliflozin in Patients with Autosomal Dominant Polycystic Kidney Disease Ended

2023-505890-34-00 Autosomal dominant polycystic kidney disease 2024-06-27
Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switc… Ended

2023-504192-25-00 HIV-1 2024-06-05
A clinical trial to evaluate efficacy, safety and cost-efficacy of gene analysis strategy in a population at risk of cardiovascular disease … Ended

2023-509418-12-00 Patients at risk of cardiovascular disease susceptible 2024-06-05
The effect of nocturnal dexmedetomidine on postoperative sleep quality and fatigue after major surgery in elderly patients: DEXSLEEP study Ended

2023-510403-22-00 Patients aged 60 years or older undergoing major surger 2024-06-03
REIMAGINE – Real-world EvaluatIon of Mepolizumab in severe Asthma achievinG on treatment clinIcal remissioN, a prospEctive study. Ended

2023-509026-21-00 severe asthma 2024-06-03
StayDry Ended

2023-510280-35-00 Daytime urinary incontinence 2024-05-27
Men4age study Ended

2024-513640-29-00 Invasive meningococcal disease, sepsis, meningitis 2024-05-13
The effect of different antibiotic protocols for dental implant surgery on peri-implant tissue health and on oral microbiome and resistome Ended

2023-510391-31-00 healthy patients 2024-05-02
Subcutaneous infliximab after a previous intravenous dose optimization (AMARETTO trial) Ended

2023-508166-15-00 Ulcerative colitis (UC), Inflammatory bowel disease typ 2024-04-29
Clinical trial to evaluate the safety and efficacy of a 7-day versus 14-day treatment for enterococcal infections. Ended

2023-508456-18-00 Uncomplicated bacteremia caused by E. faecalis or E. fa 2024-04-29
KetCRPS-2 Ended

2024-511877-31-00 Complex regional pain syndrome 2024-04-22
The efficacy of aprepitant for the prevention of postoperative nausea and vomiting after bariatric surgery. Ended

2023-508849-40-00 Postoperative nausea and vomiting 2024-04-11
MAGNETICAL - MAGNetic resonance Evaluation of Tafamidis Impact in Cardiac AmyLoidosis Ended

2024-518708-29-00 Transthyretin cardiac amyloidosis 2024-03-13